Comparative Cytotoxicity of Artemisinin and Cisplatin and Their Interactions with Chlorogenic Acids in MCF7 Breast Cancer Cells

被引:72
|
作者
Suberu, John O. [2 ]
Romero-Canelon, Isolda [3 ]
Sullivan, Neil [4 ]
Lapkin, Alexei A. [2 ]
Barker, Guy C. [1 ]
机构
[1] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England
[2] Univ Cambridge, Cambridge CB2 3RA, England
[3] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England
[4] SensaPharm Ltd, Biosci Ctr 123I, Sunderland SR5 2TA, England
基金
英国工程与自然科学研究理事会; 英国生物技术与生命科学研究理事会;
关键词
antagonism; Artemisia tea; artemisinin; chlorogenic acid; cisplatin; synergy; ANNUA TEA INFUSION; IN-VITRO; ANTIMALARIAL ACTIVITY; CAFFEIC ACID; HERBAL TEA; QING-HAO; ARTESUNATE; POLYPHENOLS; RESISTANCE; INHIBITION;
D O I
10.1002/cmdc.201402285
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In parts of Africa and Asia, self-medication with a hot water infusion of Artemisia annua (Artemisia tea) is a common practice for a number of ailments including malaria and cancer. In our earlier work, such an extract showed better potency than artemisinin alone against both chloroquine-sensitive and -resistant parasites. In this study, in vitro tests of the infusion in MCF7 cells showed high IC50 values (>200M). The combination of artemisinin and 3-caffeoylquinic acid (3CA), two major components in the extract, was strongly antagonistic and gave a near total loss of cytotoxicity for artemisinin. We observed that the interaction of 3CAs with another cytotoxic compound, cisplatin, showed potentiation of activity by 2.5-fold. The chelation of cellular iron by 3CA is hypothesized as a possible explanation for the loss of artemisinin activity.
引用
收藏
页码:2791 / 2797
页数:7
相关论文
共 50 条
  • [1] A meta-analysis assessing the cytotoxicity of nanoparticles on MCF7 breast cancer cells
    Konuk, Elcin Yenidunya
    ONCOLOGY LETTERS, 2024, 28 (05)
  • [2] The effectiveness of oracin in enhancing the cytotoxicity of doxorubicin through the inhibition of doxorubicin deactivation in breast cancer MCF7 cells
    Hanusova, V.
    Kralova, V.
    Schroeterova, L.
    Trilecova, L.
    Pakostova, A.
    Skalova, L.
    XENOBIOTICA, 2010, 40 (10) : 681 - 690
  • [3] The effect of dietary polyphenols on the epigenetic regulation of gene expression in MCF7 breast cancer cells
    Paluszczak, Jaroslaw
    Krajka-Kuzniak, Violetta
    Baer-Dubowska, Wanda
    TOXICOLOGY LETTERS, 2010, 192 (02) : 119 - 125
  • [4] Effect of survivin siRNA on biological behaviour of breast cancer MCF7 cells
    Wang, Hao
    Ye, Yi-Feng
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2015, 8 (03) : 225 - 228
  • [5] Modification of gene expression induced by siRNA targeting of estrogen receptor a in MCF7 human breast cancer cells
    Luqmani, Y. A.
    Al Azmi, A.
    Al Bader, M.
    Abraham, G.
    El Zawahri, M.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 34 (01) : 231 - 242
  • [6] Differentially Expressed Mitochondrial Proteins in Human MCF7 Breast Cancer Cells Resistant to Paclitaxel
    Daniel, Petr
    Halada, Petr
    Jelinek, Michael
    Balusikova, Kamila
    Kovar, Jan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (12)
  • [7] Chronic-Leptin Attenuates Cisplatin Cytotoxicity in MCF-7 Breast Cancer Cell Line
    Nadal-Serrano, Mercedes
    Sastre-Serra, Jorge
    Valle, Adamo
    Roca, Pilar
    Oliver, Jordi
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 36 (01) : 221 - 232
  • [8] Nrf2 is the key to chemotherapy resistance in MCF7 breast cancer cells under hypoxia
    Syu, Jhih-Pu
    Chi, Jen-Tsan
    Kung, Hsiu-Ni
    ONCOTARGET, 2016, 7 (12) : 14659 - 14672
  • [9] Homocamptothecin-daunorubicin association overcomes multidrug-resistance in breast cancer MCF7 cells
    Chauvier, D
    Morjani, H
    Manfait, M
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 73 (02) : 113 - 125
  • [10] Homocamptothecin-Daunorubicin Association Overcomes Multidrug-Resistance in Breast Cancer MCF7 Cells
    David Chauvier
    Hamid Morjani
    Michel Manfait
    Breast Cancer Research and Treatment, 2002, 73 : 113 - 125